Home
Resources
Publications
Hexaminolevulinate Hydrochloride Blue-Light Flexible Cystoscopy in the Detection and Follow-Up of Nonmuscle-Invasive Bladder Cancer: Cost Consequences During Outpatient Surveillance in Sweden

Hexaminolevulinate Hydrochloride Blue-Light Flexible Cystoscopy in the Detection and Follow-Up of Nonmuscle-Invasive Bladder Cancer: Cost Consequences During Outpatient Surveillance in Sweden

Viktor Dansk, Per-Uno Malmström, Mats Bläckberg, Maria Malmenäs

Future Oncol. 2016;12(8):1025-38.

PMID: 26975197

Abstract:

Aim:
This study explored the cost consequences of introducing hexaminolevulinate hydrochloride-guided blue-light flexible cystoscopy (HAL BLFC) as an adjunct to white-light flexible cystoscopy compared with white-light flexible cystoscopy alone, for the detection and management of nonmuscle invasive bladder cancer in Sweden.
Methods:
The model evaluated 231 patients in the outpatient setting after successful initial transurethral resection of the bladder tumor.
Results:
HAL BLFC introduction across all risk groups resulted in minimal budget impact (+1.6% total cost/5 years, or 189 Swedish Krona [SEK] per patient/year), and translated to cost savings in intermediate- and high-risk groups from year 2.
Conclusion:
HAL BLFC allowed more outpatient treatment with improved recurrence detection and reduced transurethral resection of the bladder tumors, cystectomies, bed days and operating room time, with minimal cost impact across all risk groups, demonstrating the economic benefits of introducing HAL.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP140898915	Hexaminolevulinate hydrochloride		140898-91-5	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: